New molecular targets for the treatment of neovascular age-related macular degeneration. Translational Medicine Reports, [S. l.], v. 2, n. 1, 2017. DOI: 10.4081/tmr.6819. Disponível em: https://www.pagepressjournals.org/tmr/article/view/6819. Acesso em: 14 may. 2026.